Britannia Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 20, 2024	Mar '24 Mar 30, 2024	Mar '23 Mar 30, 2023	Mar '22 Mar 30, 2022	Mar '21 Mar 30, 2021	Mar '20 Mar 30, 2020
Market Capitalization	13	11	15	31	-	-
Market Cap Growth	-7.69%	-26.32%	-49.89%	-	-	-
Enterprise Value	24	21	25	38	-	-
Last Close Price	0.08	0.07	0.10	0.19	-	-
PE Ratio	-	-	3.03	-	-	-
PS Ratio	1.79	1.50	2.41	4.21	-	-
PB Ratio	8.55	1.70	1.39	5.61	-	-
P/FCF Ratio	13.30	5.80	7.89	11.34	-	-
P/OCF Ratio	9.75	5.43	7.67	10.99	-	-
EV/Sales Ratio	3.32	2.76	3.90	5.26	-	-
EV/EBITDA Ratio	17.87	14.82	22.64	21.88	-	-
EV/EBIT Ratio	18.46	16.24	25.15	23.75	-	-
EV/FCF Ratio	24.73	10.68	12.80	14.15	-	-
Debt / Equity Ratio	1.20	1.09	0.76	0.95	3.96	-
Debt / EBITDA Ratio	6.00	4.80	7.31	2.88	32.63	-
Debt / FCF Ratio	7.62	3.72	4.31	1.92	-	-
Asset Turnover	0.31	0.33	0.29	0.34	0.13	-
Quick Ratio	0.23	0.24	0.91	0.41	0.25	1.03
Current Ratio	0.25	0.26	0.92	0.42	0.25	1.03
Return on Equity (ROE)	-75.63%	-49.61%	70.57%	-343.40%	10.72%	-
Return on Assets (ROA)	2.93%	3.51%	2.78%	4.75%	1.67%	-
Return on Capital (ROIC)	4.08%	4.81%	4.12%	8.46%	2.73%	-
Earnings Yield	-56.29%	-41.98%	32.98%	-50.26%	-	-
FCF Yield	7.52%	17.23%	12.67%	8.82%	-	-
Buyback Yield / Dilution	-0.03%	-0.07%	-48.07%	-41.06%	-1138.07%	-
Total Shareholder Return	-0.03%	-0.07%	-48.07%	-41.06%	-1138.07%	-

Source: S&P Capital IQ. Standard template. Financial Sources.